Kenneth C. Carter, President and CEO at AVALON PHARMACEUTICALS INC (AVRX), sold 1,400 shares at $2.65 ($4K) on 2008-01-17, disclosed to the SEC on 2008-01-25.
Open-market sale of $4k AVRX by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| AVRX | BUY | 2006-08-31 | $9K | — | Filing → |
| AVRX | BUY | 2006-08-24 | $7K | — | Filing → |